{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T21:09:37Z","timestamp":1783976977956,"version":"3.55.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.humpath.2026.106206","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T23:48:04Z","timestamp":1782431284000},"page":"106206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mixed phenotype acute leukemia: Lineage assignment, immunophenotypic classification and genetic insights"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1145-3550","authenticated-orcid":false,"given":"Vasiliki","family":"Leventaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9385-9911","authenticated-orcid":false,"given":"Sa A.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.humpath.2026.106206_bib1","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.humpath.2026.106206_bib2","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2026.106206_bib3","article-title":"Clinical outcomes of adult patients with newly diagnosed mixed phenotype acute leukemia","volume":"9","author":"Goulart","year":"2025","journal-title":"JCO Precis Oncol"},{"issue":"7","key":"10.1016\/j.humpath.2026.106206_bib4","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1038\/s41375-018-0058-4","article-title":"Therapy for children and adults with mixed phenotype acute leukemia: a systematic review and meta-analysis","volume":"32","author":"Maruffi","year":"2018","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.humpath.2026.106206_bib5","first-page":"1783","article-title":"Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL)","volume":"9","author":"Bene","year":"1995","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.humpath.2026.106206_bib6","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/bjh.12277","article-title":"Flow cytometry thresholds of myeloperoxidase detection to discriminate between acute lymphoblastic or myeloblastic leukaemia","volume":"161","author":"Guy","year":"2013","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.humpath.2026.106206_bib7","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/bjh.17210","article-title":"Standardised immunophenotypic analysis of myeloperoxidase in acute leukaemia","volume":"193","author":"Bras","year":"2021","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.humpath.2026.106206_bib8","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1309\/UJUL60UPUP3YJE93","article-title":"Expression of the B cell-associated transcription factors PAX5, OCT-2, and BOB.1 in acute myeloid leukemia: associations with B-cell antigen expression and myelomonocytic maturation","volume":"126","author":"Gibson","year":"2006","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.humpath.2026.106206_bib9","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/path.1126","article-title":"Immunohistochemical detection of CD79a expression in precursor T cell lymphoblastic lymphoma\/leukaemias","volume":"197","author":"Hashimoto","year":"2002","journal-title":"J Pathol"},{"issue":"2","key":"10.1016\/j.humpath.2026.106206_bib10","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/(SICI)1096-9896(1998100)186:2<140::AID-PATH149>3.0.CO;2-Y","article-title":"Co-expression of CD79a (JCB117) and CD3 by lymphoblastic lymphoma","volume":"186","author":"Pilozzi","year":"1998","journal-title":"J Pathol"},{"issue":"1","key":"10.1016\/j.humpath.2026.106206_bib11","first-page":"35","article-title":"Clinical significance of CD10 expression in childhood acute lymphoblastic leukemia","volume":"7","author":"Pui","year":"1993","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.humpath.2026.106206_bib12","first-page":"452","article-title":"[Clinicopathologic study of 128 cases of T-lymphoblastic lymphoma\/leukemia]","volume":"39","author":"Yu","year":"2010","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"issue":"1","key":"10.1016\/j.humpath.2026.106206_bib13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/ajcp\/aqac070","article-title":"How I diagnose acute leukemia of ambiguous lineage","volume":"158","author":"Weinberg","year":"2022","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2026.106206_bib14","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.humpath.2021.05.007","article-title":"CD2 and CD7 are sensitive flow cytometry screening markers for T-lineage acute leukemia(s): a study of 465 acute leukemia cases","volume":"114","author":"Rozenova","year":"2021","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.humpath.2026.106206_bib15","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/bjh.12484","article-title":"Cytogenetic abnormalities in acute leukaemia of ambiguous lineage: an overview","volume":"163","author":"Manola","year":"2013","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.humpath.2026.106206_bib16","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1038\/s41467-018-04924-z","article-title":"Integrative genomic analysis of adult mixed phenotype acute leukemia delineates lineage associated molecular subtypes","volume":"9","author":"Takahashi","year":"2018","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.humpath.2026.106206_bib17","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1182\/blood-2010-10-314682","article-title":"Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification","volume":"117","author":"Matutes","year":"2011","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.humpath.2026.106206_bib18","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1309\/AJCPPVUPOTUVOIB5","article-title":"Mixed phenotype acute leukemia: a study of 61 cases using World Health Organization and European Group for the Immunological Classification of Leukaemias criteria","volume":"142","author":"Weinberg","year":"2014","journal-title":"Am J Clin Pathol"},{"issue":"11","key":"10.1016\/j.humpath.2026.106206_bib19","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.3324\/haematol.2012.064485","article-title":"Clinical, immunophenotypic, cytogenetic, and molecular genetic features in 117 adult patients with mixed-phenotype acute leukemia defined by WHO-2008 classification","volume":"97","author":"Yan","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.humpath.2026.106206_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2026.101016","article-title":"Genetic profile, treatment response, and outcomes of BCR::ABL1-Positive mixed-phenotype acute leukemia: a study from the BCR::ABL1 pathology group","author":"Shen","year":"2026","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.humpath.2026.106206_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.31507","article-title":"Genomic and clinicopathological characterization of CRLF2-Rearranged mixed phenotype acute leukemia","volume":"72","author":"Han","year":"2025","journal-title":"Pediatr Blood Cancer"},{"issue":"7727","key":"10.1016\/j.humpath.2026.106206_bib22","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41586-018-0436-0","article-title":"The genetic basis and cell of origin of mixed phenotype acute leukaemia","volume":"562","author":"Alexander","year":"2018","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.humpath.2026.106206_bib24","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1158\/2643-3230.BCD-21-0163","article-title":"ZNF384 fusion oncoproteins drive lineage aberrancy in acute leukemia","volume":"3","author":"Dickerson","year":"2022","journal-title":"Blood Cancer Discov"},{"issue":"1","key":"10.1016\/j.humpath.2026.106206_bib25","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/ajh.26758","article-title":"Integrative genomic and transcriptomic profiling reveals distinct molecular subsets in adult mixed phenotype acute leukemia","volume":"98","author":"Wang","year":"2023","journal-title":"Am J Hematol"},{"issue":"11","key":"10.1016\/j.humpath.2026.106206_bib26","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1038\/leu.2017.70","article-title":"The T-ALL related gene BCL11B regulates the initial stages of human T-cell differentiation","volume":"31","author":"Ha","year":"2017","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.humpath.2026.106206_bib27","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/ni.3514","article-title":"Asynchronous combinatorial action of four regulatory factors activates Bcl11b for T cell commitment","volume":"17","author":"Kueh","year":"2016","journal-title":"Nat Immunol"},{"issue":"9","key":"10.1016\/j.humpath.2026.106206_bib28","first-page":"773","article-title":"14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia","volume":"138","author":"Di Giacomo","year":"2021","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.humpath.2026.106206_bib29","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1038\/s41375-020-0761-9","article-title":"T(6;14)(q25;q32) involves BCL11B and is highly associated with mixed-phenotype acute leukemia, T\/myeloid","volume":"34","author":"Wang","year":"2020","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.humpath.2026.106206_bib23","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1158\/2159-8290.CD-21-0145","article-title":"Enhancer hijacking drives oncogenic BCL11B expression in lineage-ambiguous stem cell leukemia","volume":"11","author":"Montefiori","year":"2021","journal-title":"Cancer Discov"},{"issue":"1","key":"10.1016\/j.humpath.2026.106206_bib30","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00428-022-03448-8","article-title":"International consensus classification of acute lymphoblastic leukemia\/lymphoma","volume":"482","author":"Duffield","year":"2023","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2026.106206_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.humpath.2026.106057","article-title":"Acute leukemia with BCL11B rearrangements: genetic landscape, BCL11B expression, and therapeutic response","volume":"171","author":"Tang","year":"2026","journal-title":"Hum Pathol"},{"issue":"12","key":"10.1016\/j.humpath.2026.106206_bib32","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1177\/10600280251341279","article-title":"Revumenib for relapsed or refractory acute leukemia with a KMT2A translocation","volume":"59","author":"Lynch","year":"2025","journal-title":"Ann Pharmacother"},{"issue":"12","key":"10.1016\/j.humpath.2026.106206_bib33","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/s41587-019-0332-7","article-title":"Single-cell multiomic analysis identifies regulatory programs in mixed-phenotype acute leukemia","volume":"37","author":"Granja","year":"2019","journal-title":"Nat Biotechnol"},{"issue":"4","key":"10.1016\/j.humpath.2026.106206_bib34","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/cyto.b.21966","article-title":"Clinical and laboratory features associated with myeloperoxidase expression in pediatric B-lymphoblastic leukemia","volume":"100","author":"McGinnis","year":"2021","journal-title":"Cytometry B Clin Cytom"},{"issue":"2","key":"10.1016\/j.humpath.2026.106206_bib35","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/ijlh.13988","article-title":"Adult mixed phenotype acute leukemia (MPAL): b\/myeloid MPAL(isoMPO) is distinct from other MPAL subtypes","volume":"45","author":"Weinberg","year":"2023","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.humpath.2026.106206_bib36","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.leukres.2018.05.009","article-title":"Cytoplasmic CD3 expression in infant acute megakaryoblastic leukemia: a new ambiguous lineage subtype?","volume":"71","author":"Rossi","year":"2018","journal-title":"Leuk Res"},{"issue":"2","key":"10.1016\/j.humpath.2026.106206_bib37","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1080\/10428194.2022.2140285","article-title":"Frequent detection of CBFA2T3::GLIS2 fusion and RAM-phenotype in pediatric non-down syndrome acute megakaryoblastic leukemia: a possible novel relationship with aberrant cytoplasmic CD3 expression","volume":"64","author":"Chen Wongworawat","year":"2023","journal-title":"Leuk Lymphoma"},{"issue":"11","key":"10.1016\/j.humpath.2026.106206_bib38","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1182\/blood.2019004434","article-title":"Microgranular acute promyelocytic leukemia with expression of T-cell markers mimicking mixed-phenotype acute leukemia","volume":"135","author":"Liu","year":"2020","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.humpath.2026.106206_bib39","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s12308-018-0329-z","article-title":"High-risk acute promyelocytic leukemia with unusual T\/Myeloid immunophenotype successfully treated with ATRA and arsenic trioxide-based regimen","volume":"11","author":"Singh","year":"2018","journal-title":"J Hematop"},{"issue":"3","key":"10.1016\/j.humpath.2026.106206_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3026(26)00006-2","article-title":"Blastic plasmacytoid dendritic cell neoplasm with aberrant cytoplasmic CD3 expression","volume":"13","author":"Li","year":"2026","journal-title":"Lancet Haematol"},{"issue":"6","key":"10.1016\/j.humpath.2026.106206_bib41","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.pathol.2025.01.007","article-title":"Acute lymphoblastic leukaemia with T- and B-lineage defining markers","volume":"57","author":"E","year":"2025","journal-title":"Pathology"},{"issue":"4","key":"10.1016\/j.humpath.2026.106206_bib42","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/bjh.12042","article-title":"The immunophenotype of T-lymphoblastic lymphoma in children and adolescents: a Children's Oncology Group report","volume":"159","author":"Patel","year":"2012","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.humpath.2026.106206_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.labinv.2025.105444","article-title":"1152 low-level lymphoblasts in patients with acute myeloid leukemia","volume":"106","author":"Al-Rusan","year":"2026","journal-title":"Laboratory Investigation"},{"issue":"1","key":"10.1016\/j.humpath.2026.106206_bib44","first-page":"98","article-title":"Reporting blast percentage for response assessment in acute leukemias: recommendations from an EHA\/ELN expert panel","volume":"111","author":"Wang","year":"2026","journal-title":"Haematologica"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817726001759?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817726001759?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T20:24:13Z","timestamp":1783974253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817726001759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":44,"alternative-id":["S0046817726001759"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106206","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mixed phenotype acute leukemia: Lineage assignment, immunophenotypic classification and genetic insights","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106206","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106206"}}